Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Purple Biotech Ltd. - American Depositary Shares (NQ:PPBT)

1.390 -0.080 (-5.44%)
Streaming Delayed Price Updated: 9:48 AM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Purple Biotech Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 56 companies set new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗
 
Via Benzinga
News headline image
Purple Biotech: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Purple Biotech's Assets Are First In Class For Solid Tumor Treatment, Analyst Says ↗
 
Via Benzinga
News headline image
This Small-Cap Cancer Stock Has Almost 400% Upside According To This Bullish Analyst ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
News headline image
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. 
Via Benzinga
News headline image
Purple Biotech Reports Positive Results of CM24 Dose Escalation in Advanced Pancreatic Cancer Patients
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Debuts Scientific Advisory Board
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Reports New Preclinical Data on Potential of NT219 to Re-sensitize Resistant Tumors to Immune Checkpoint Inhibitors
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Reports Biomarker Data from CM24 Phase 1 Dose Escalation Study
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments
As a subsidiary of Clalit Healthcare Services, Israel’s largest HMO, Mor Research Applications brings Purple Biotech first access to research conducted at 14 hospitals The collaboration with Mor... 
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's trading, 138 companies set new 52-week lows. 
Via Benzinga
News headline image
Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech to Present at the Jefferies London Healthcare Conference
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Purple Biotech Appoints Lior Fhima as Chief Financial Officer
From Purple Biotech Ltd.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022 ↗
Upgrades 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
34 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 37.7% to $4.64. Emclaire Financial Corp (NASDAQ: EMCF) shares climbed 32.8% to $38.35 after the company and... 
Via Benzinga
News headline image
63 Biggest Movers From Yesterday ↗
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, trader! It's time for another round of the biggest pre-market stock movers before the opening bell on Thursday! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.